This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lorus Therapeutics Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Robert Peralta
Introduction
Robert Peralta is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective solutions for various types of cancer, showcasing his dedication to improving patient outcomes.
Latest Patents
Robert Peralta holds a patent for "2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer." This invention provides compounds that are capable of inhibiting the proliferation of renal cancer cells, pancreatic cancer cells, prostate cancer cells, colon cancer cells, leukemia cells, brain cancer/tumor cells, and non-small cell lung cancer cells. His patent represents a significant advancement in the fight against cancer, offering hope for more effective treatments.
Career Highlights
Throughout his career, Robert has been associated with Lorus Therapeutics Inc., a company dedicated to developing innovative cancer therapies. His work at Lorus Therapeutics has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his research.
Collaborations
Robert Peralta has worked alongside esteemed colleagues such as Yoon S Lee and Howard Cukier. These collaborations have contributed to the development of groundbreaking cancer treatments and have fostered a spirit of innovation within the research community.
Conclusion
Robert Peralta's contributions to cancer research and treatment exemplify the power of innovation in medicine. His patented compounds offer promising avenues for combating various forms of cancer, highlighting the importance of continued research and collaboration in this critical field.